Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Progesterone for Marijuana Reduction in Co-Users
NCT02579421Completed
- Sponsor
- University of Minnesota
- Start
- Nov 2015
- Primary completion
- Jul 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial of progesterone in cannabis use disorder (CUD) (4 arms), sponsored by University of Minnesota. Primary endpoint: Change in Marijuana Use as Defined by the TLFB at 4 weeks. Started Nov 2015; status: completed.
02
Drugs
progesterone
03
Conditions
cannabis use disorder (CUD)
Beyond the preview
Go deeper on NCT02579421.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02579421.